Sidley represented underwriters Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Stifel, Nicolaus & Company, and RBC Capital Markets, LLC in connection with the US$110 million initial public offering of Contineum Therapeutics, Inc. (“Contineum”), a clinical stage biopharmaceutical company. Contineum’s common stock trades on the Nasdaq Global Select Market under the symbol “CTNM.”

The deal team was led by Frank Rahmani (Capital Markets, Emerging Companies and Venture Capital), Sam Gandhi (Capital Markets), and Carlton Fleming (Capital Markets, Emerging Companies and Venture Capital), and included Kostian Ciko (Capital Markets) and Samantha Carvalho (M&A).~~Sidley represented underwriters Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Stifel, Nicolaus & Company, and RBC Capital Markets, LLC in connection with the US$110 million initial public offering of Contineum Therapeutics, Inc. (“Contineum”), a clinical stage biopharmaceutical company. Contineum’s common stock trades on the Nasdaq Global Select Market under the symbol “CTNM.”

The deal team was led by Frank Rahmani (Capital Markets, Emerging Companies and Venture Capital), Sam Gandhi (Capital Markets), and Carlton Fleming (Capital Markets, Emerging Companies and Venture Capital), and included Kostian Ciko (Capital Markets) and Samantha Carvalho (M&A).